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INTRODUCTION
Receptor-linked protein tyrosine phosphatases (RPTPs)
regulate axon guidance and synaptogenesis decisions in
Drosophila embryos and larvae. Five Drosophila RPTPs have
been described, and four of these are selectively expressed on
central nervous system (CNS) axons (Desai et al., 1994;
Hariharan et al., 1991; Streuli et al., 1989; Sun et al., 2000;
Tian et al., 1991; Yang et al., 1991). They do not obviously
define distinct sets of pathways, as they appear to be expressed
on most or all CNS axons. DPTP4E mRNA is widely
expressed, but its protein distribution pattern is unknown (Oon
et al., 1993). 
The four ‘neural’ RPTPs DPTP10D, DLAR, DPTP69D and
DPTP99A have been studied using genetics. All four regulate
axon guidance decisions in embryos (Desai et al., 1996; Desai
et al., 1997; Krueger et al., 1996; Sun et al., 2000; Sun et al.,
2001; Wills et al., 1999). Ptp69D, Dlar (Lar – FlyBase) and
Ptp10D mutations also cause optic lobe innervation defects in
larvae and pupae (Garrity et al., 1999; Newsome et al., 2000)
(T. Suzuki et al., and Q. Sun and K. Z., unpublished).
Single mutants that lack DLAR or DPTP69D have guidance
phenotypes affecting specific pathway decisions made by
embryonic motor axons (Desai et al., 1996; Krueger et al.,
1996). However, most guidance decisions within the
neuromuscular system are altered only when specific
combinations of two or more RPTPs are eliminated, indicating
that RPTPs can have partially redundant functions at growth
cone choice points (Desai et al., 1996; Desai et al., 1997; Sun
et al., 2000; Sun et al., 2001). 
RPTPs can also have ‘competitive’ activities, in a formal
genetic sense. DLAR and DPTP99A function in opposition to
each other in regulating entry of the ISNb motor nerve into its
target ventrolateral muscle (VLM) field (Desai et al., 1997).
The Abl tyrosine kinase and its substrate Ena are also involved
in DLAR signaling at this decision point (Wills et al., 1999). 
Little is known about the biochemical mechanisms involved
in control of motor axon guidance by RPTPs. The ligands
and/or co-receptors that might interact with their extracellular
(XC) domains have not been identified. The in vivo substrates
for fly RPTPs are also unknown, although several proteins that
they can dephosphorylate in vitro or in transfected cells have
been described (Fashena and Zinn, 1997; Wills et al., 1999).
None of the previously characterized Rptp single mutants
has strong phenotypes that affect the array of axons within the
CNS, as assayed by staining with several different antibody
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Receptor-linked protein tyrosine phosphatases (RPTPs)
regulate axon guidance and synaptogenesis in Drosophila
embryos and larvae. We describe DPTP52F, the sixth
RPTP to be discovered in Drosophila. Our genomic analysis
indicates that there are likely to be no additional RPTPs
encoded in the fly genome. Five of the six Drosophila RPTPs
have C. elegans counterparts, and three of the six are also
orthologous to human RPTP subfamilies. DPTP52F,
however, has no clear orthologs in other organisms. The
DPTP52F extracellular domain contains five fibronectin
type III repeats and it has a single phosphatase domain.
DPTP52F is selectively expressed in the CNS of late
embryos, as are DPTP10D, DLAR, DPTP69D and
DPTP99A. To define developmental roles of DPTP52F, we
used RNA interference (RNAi)-induced phenotypes as a
guide to identify Ptp52F alleles among a collection of EMS-
induced lethal mutations. Ptp52F single mutant embryos
have axon guidance phenotypes that affect CNS
longitudinal tracts. This phenotype is suppressed in Dlar
Ptp52F double mutants, indicating that DPTP52F and
DLAR interact competitively in regulating CNS axon
guidance decisions. Ptp52F single mutations also cause
motor axon phenotypes that selectively affect the SNa
nerve. DPTP52F, DPTP10D and DPTP69D have partially
redundant roles in regulation of guidance decisions made
by axons within the ISN and ISNb motor nerves.
Key words: Receptor tyrosine phosphatase, PTP, Drosophila, Neural
development, Axon guidance, Neuromuscular system, Genomics,
Motor axon, RNAi
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markers. Removal of both DPTP10D and DPTP69D, however,
generates a unique phenotype in which many longitudinal
axons abnormally cross the midline (Sun et al., 2000). The
Ptp10D Ptp69D double mutation interacts with roundabout,
commissureless and slit, a set of mutations defining a pathway
that repels longitudinal axons from the midline and prevents
commissural axons from recrossing it (Zinn and Sun, 1999). 
We describe DPTP52F, which is probably the last remaining
RPTP encoded in the Drosophila genome. Ptp52F mutations
cause specific CNS and motor axon guidance phenotypes, and
exhibit genetic interactions with mutations in the other Rptp
genes. 
MATERIALS AND METHODS
Genetics
In an screen to isolate mutations in the Drosophila Lissencephaly 1
(DLis-1; Lis1 – FlyBase) gene, 18,000 independent EMS mutations
were isolated (J. Duncan and R. W.; a complete description will be
published elsewhere). 183 mutations were identified that are lethal
when placed in trans to the deficiency Df(2R)JP6, which includes the
DLis-1 and Ptp52F genes. These mutations were subdivided by
testing for lethality over two overlapping deficiencies, Df(2R)JP4 and
Df(2R)JP8 (Fig. 1). 70 mutations in 13 complementation groups were
lethal in trans to all three deficiencies, and eight Ptp52F alleles were
identified among these. 
For genetic interaction studies, we used the alleles Ptp10D1 (Sun
et al., 2000), Dlar5.5 (Krueger et al., 1996), the transheterozygous
combination Ptp69D1/Df(3L)8ex25 (Desai et al., 1996) and Ptp99A1
(Hamilton et al., 1995). 
Molecular biology
PCR amplification of DPTP52F, DPTP26C and DPTP36E fragments
was performed on phage stocks of a 9-12 hr l gt11 library (Zinn et al.,
1988) using primers designed from genomic sequences. cDNA clones
were isolated from this and other libraries, including a random-primed
9-12 hour l ZAPII library (K. Z., unpublished), by hybridization to
these PCR fragments. We were only able to obtain one cDNA clone
encoding a portion of the DPTP52F extracellular (XC) domain. The
sequence of this cDNA could encode an open reading frame of 881
amino acids, corresponding to the C-terminal section of the predicted
protein CG18243 (1419 amino acids) in Release 2 of GadFly. A
number of in-frame stop codons are located upstream of the ATG for
the reading frame, which is at nucleotide 580 of our cDNA. However,
a comparison of the sequence of our cDNA to the genome sequence
revealed that an intron upstream of this ATG had not been completely
removed. In the cDNA, the 5¢ splice site of this intron is fused to
sequences within the intron, and the fusion joins the 5 ¢ splice site to
a site near the branchpoint, 14 nucleotides 5 ¢ to the acceptor site. This
cDNA is thus a copy of an aberrantly spliced RNA. All other introns
within the cDNA sequence were removed in a normal manner. To
define the complete coding region for DPTP52F, we then performed
reverse transcription-PCR (RT-PCR) experiments on primary
embryonic first-strand cDNA preparations. We used a 3¢ primer within
the cDNA, downstream of the aberrantly spliced intron, and a series
of 5¢ primers, the most 5¢ of which was upstream of the ATG of
CG18243 (in the presumed 5 ¢ UTR of the CG18243 mRNA; primer
sequences available on request). (CG18243 has no ESTs, so its
predicted mRNA has no 5 ¢ UTR; it begins with the ATG of the
predicted protein.) Analysis of the cloned PCR products revealed that
the DPTP52F protein sequence begins with the initiating methionine
of CG18243. There are several in-frame stop codons immediately
upstream of this ATG, so the protein must start here. The authentic
DPTP52F sequence is very similar to CG18243, except that the intron
that was incompletely removed from our cDNA (intron 3) does not
use the predicted CG18243 5 ¢ splice site, but rather uses a 5 ¢ splice
site 42 nucleotides downstream. This is the same 5 ¢ splice site that
was fused to the branchpoint sequence in our clone. The actual 3 ¢
splice site of this intron is as predicted for CG18243. Joining these
splice sites preserves the CG18243 reading frame, so the DPTP52F
protein contains an extra 14 amino acids, making the entire preprotein
1433 amino acids in length.
dsRNA-mediated genetic interference
This was performed essentially as described in the Carthew laboratory
protocol (http://www.pitt.edu/~carthew/manual/RNAi_Protocol.html)
(Kennerdell and Carthew, 1998; Schmid et al., 2001). Sequences to
be transcribed into dsRNAs were cloned into Bluescript KS+,
linearized with the appropriate restriction enzymes, and transcribed in
vitro with Ambion T3 and T7 Megascript kits following the
manufacturer’s instructions. Transcripts were annealed in injection
buffer (0.1 mM NaPO4, pH 7.8/5 mM KCl) after heating to 95°C for
1 minute and cooled gradually to room temperature by placing the
water bath in a foam box over a 18 hour period. We typically injected
~0.1 nl of 0.5-2.0 m M solutions of dsRNAs. The Ptp52F dsRNAs
corresponded to Ptp52F sequences spanning nucleotides 1279-2444
and nucleotides 2105-3998 (counting from the initiating ATG). Cages
were set up using 2- to 4-day-old Oregon R flies. Eggs were collected
over a 15- to 30-minute period on grape juice agar plates for
subsequent injection. The eggs were lined up lengthwise on double
stick tape on a glass slide and immersed in halocarbon oil. Syncitial
blastoderm embryos were injected at ~50% egg length (EL) using an
Eppendorf transjector. After injection, embryos were allowed to
develop to stage 16-17 under oil in a moist chamber. 
Antibody production
A fragment of the extracellular domain of DPTP52F (amino acids
572-1037) tagged with His6 was expressed in E. coli at the Caltech
Protein Expression Facility. Monoclonal antibodies (mAbs) against
this fusion protein were generated at the Caltech Monoclonal
Antibody Facility and screened based on their ability to recognize the
fusion protein on dot blots and by staining of whole mount embryos.
mAb 13B8, which worked well for immunostaining of whole mount
embryos (Fig. 2), was used at a 1:3 dilution.
Immunohistochemistry
Embryos were collected from crosses between flies bearing various
combinations of mutant alleles. The desired mutant embryos were
identified based on the absence of staining with mAbs specific for
each RPTP and/or by the absence of staining with anti- b -galactosidase
mAb (Promega), which detects the presence of the lacZ gene on the
balancer chromosomes. Anti-RPTP mAbs used were 3A6 (DPTP99A)
(Tian et al., 1991), 45E10 (DPTP10D) (Tian et al., 1991), 3F11
(DPTP69D) (Desai et al., 1994) and 8C4 (DLAR) (Sun et al., 2000).
Mutant embryos were then restained with mAb 1D4 (Van Vactor et
al., 1993) to reveal motor axon and CNS pathways, dissected, and
photographed with a Magnafire digital camera on a Zeiss Axioplan
microscope using Nomarski optics. All mAb supernatants were used
at 1:5 to 1:10 dilutions. Antibody staining using horseradish
peroxidase (HRP) immunohistochemistry was performed as described
(Patel, 1994). Amplification of the HRP signal was performed using
a Vectastain Elite kit (Vector Laboratories).
Database searches
Celera scaffold sequence (Venter et al., 2001) was searched with
blastn using cDNA sequences encoding each human PTP named in
a publication. PTP protein sequences were used to search the same
database using tblastn, and correlations were made between
scaffolds and known RPTPs. Unknown PTP-related sequences were
examined further to determine if they are pseudogenes. The names
of all 19 human RPTP-like proteins, with an Accession Number for
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Fig. 1. The Ptp52F gene. (A) Map of the deficiencies used for the EMS lethal screen. The position of the Ptp52F gene is indicated by the
shaded bar. (B) Exon maps of Ptp52F and the adjacent DLis1 genes; distal (toward the telomere) is towards the left, so the orientation is flipped
relative to A. (C) Sequence of the DPTP52F preprotein. Indicated sequences are: putative signal sequence, thin underline; FN3 repeats, thick
underlines; putative transmembrane domain, double underline; PTP domain, broken underline; bold, highly conserved PTP domain residues;
letters in shaded bars, amino acid changes produced by mutations. (D) Lineup of the DPTP52F FN3 repeats with two FN3 repeats from
DPTP10D and the seventh FN3 repeat in human fibronectin. Shaded bars, conserved residues. Consensus residues indicated in bold.  
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a reference sequence for each, are HPTP b= PTP b ( X54131),
HPTP h =DEP-1=CD148 (D37781), GLEPP-1=PTP-U2 (U20489),
Sap-1 (D15049), PTP-RQ=PTP-GMC1 (human fragment (134
amino acids) is AF169351, rat rPTP-GMC1 (full sequence) is
AF063249), LAR (Y00815), PTP d (L38929), PTP s (U35234),
PTP m (X58288), PTP k (L77886), RPTP r =PTPRT (AF043644),
PTP o =PTPRO=hPTP-J=PCP-2=R-PTP- y =PTP- p ,=PTPRU=PTP r
(U71075), PTP z= RPTP b (M93426), PTP g (L09247), PTP a
(M34668), PTP e (X54134), CD45=LCA (Y00062), IA-2=512
antigen=PTP35 (L18983), and phogrin=IA-2 b =PTP-NP=PTP-
IAR=ICAAR=PTP-X (AB002385) (the last two are catalytically
inactive). The reference sequences and scaffolds of the 16
cytoplasmic PTPs and the nine new PTP pseudogenes we defined
are available on request. Our conclusions regarding orthologous
relationships between fly, worm and human RPTPs differ from those
in a recent review (Walchli et al., 2000). These authors defined
orthologs based solely on E values of blastp searches with PTP
domains, and did not consider whether homology extends over the
entire protein. As these E values are very similar for many pairs of
PTP domains, and such values are highly sensitive to gap length,
this is not a good way to determine orthologs. For example, they
assigned DPTP69D as the CD45 ortholog, and DPTP99A as the
PTP g ortholog, but there are no relationships between the XC
domain sequences within these pairs. 
RESULTS
Identification and characterization of the sixth
Drosophila RPTP gene 
The five previously known Drosophila RPTP genes were
all identified by low-stringency hybridization and PCR
experiments (Hariharan et al., 1991; Streuli et al., 1989; Tian
et al., 1991; Yang et al., 1991; Oon et al., 1993). Three
cytoplasmic PTP genes have also been characterized: csw, Ptp-
ER and Ptp61F (Karim and Rubin, 1999; McLaughlin and
Dixon, 1993; Perkins et al., 1992). Mutant alleles have been
isolated for all of the Rptp and cytoplasmic PTP genes except
Ptp4E and Ptp61F.
We performed searches of the Berkeley Drosophila Genome
Project (BDGP) genomic sequence database for additional PTP
sequences in 1998 and 1999. When these searches were
conducted, about 25% of the sequence was available, but much
of it was in unordered pieces. We found PTP sequence
fragments at three cytological locations: 26C, 36E and 52F.
These fragments all encoded a sequence closely related to
VHCSAGRGV, the canonical PTP active-site motif (Fauman
and Saper, 1996). We isolated and sequenced cDNA clones
encoding these three PTPs. Analysis of these sequences
showed that we had identified two cytoplasmic PTPs
(DPTP26C and DPTP36E) and an RPTP (DPTP52F). 
Our analysis of cDNA clones and PCR products showed that
the DPTP52F preprotein is 1433 amino acids in length (see
Materials and Methods for details). The amino acid sequence
immediately following the initiating methionine has a 23
amino acid uncharged region (amino acids 15-38) and
resembles a signal peptide. A single predicted transmembrane
domain is located at residues 1038-1062. The XC domain has
17 potential N-linked glycosylation sites. Its C-terminal region
(amino acids ~370-1037) contains five fibronectin type III
(FN3) repeats like those found in other Drosophila RPTPs.
FN3 repeats are also found in many adhesion and extracellular
matrix molecules (Fig. 1D). The N-terminal 370 amino acids
of the XC domain is not significantly related to any other
sequences in the database.
Among published RPTP sequences, DPTP52F is most
similar overall to DPTP4E (42% similarity), although they
differ in the number of FN3 repeats in their XC domains (five
versus 13). DPTP52F has a single cytoplasmic phosphatase
domain that is 32-36% identical in sequence to the PTP
domains of the other known Drosophila RPTPs.
We were unable to detect DPTP52F mRNA by in situ
hybridization to embryos, suggesting that it is expressed at very
low levels. We generated mAbs against the XC domain of
DPTP52F, and used these to perform immunohistochemical
staining of whole-mount embryos. Expression of DPTP52F is
observed at the cellular blastoderm stage. During formation of
the ventral furrow, DPTP52F can be detected on cells flanking
the invaginating region (Fig. 2A). 
Later in development (stages 13-17), DPTP52F is selectively
expressed in the CNS (Fig. 2B). This CNS specificity
resembles that seen for the four ‘neural RPTPs’ DPTP10D,
DLAR, DPTP69D and DPTP99A (Desai et al., 1994;
Hariharan et al., 1991; Sun et al., 2000; Tian et al., 1991; Yang
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Fig. 2. Expression of DPTP52F protein. Whole-
mount embryos were stained with mAb 13B8
using HRP immunohistochemistry. (A) A ventral
view of a gastrulating embryo, showing
DPTP52F at the edges of the ventral furrow
(arrow). At this stage, DPTP52F is on the
membranes of all cells in the embryo at lower
levels. (B) A side view (anterior towards the left)
of a stage 15 embryo. The ventral nerve cord
(arrow) expresses DPTP52F. (C) Two segments
of a dissected CNS from a stage 15 wild-type
embryo. DPTP52F is expressed on cell bodies;
axon tracts (arrow) are lighter. (D) A dissected
CNS from a stage 15 Ptp52F18.3 embryo. No
staining is observed. 
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et al., 1991). These RPTPs, however, are localized to axons and
are present only at very low levels on neuronal cell bodies. By
contrast, DPTP52F appears to be expressed primarily on
neuronal cell bodies (Fig. 2C). 
By amplifying the antibody signal, we can sometimes detect
CNS axon bundles that appear to be positive for DPTP52F
staining (data not shown). We cannot state with certainty that
these axons express DPTP52F, however, as they are on top of
positive cell bodies, and some or all of the brown color of the
axon bundles could be due to these underlying cells. 
The absence of motor axon staining with anti-DPTP52F is
not surprising, because these axon bundles are thin and
therefore do not stain strongly. We also cannot visualize
expression of DLAR or DPTP99A on motor axons in wild-type
embryos, and DPTP10D can only be detected on the SNa nerve
(Sun et al., 2000; Sun et al., 2001). Determining that these
other RPTPs are axonally localized was not a problem,
however, because visualization of positive axon bundles within
the CNS was not impaired by staining of underlying cell
bodies. 
Df(2R)JP4/Df(2R)JP8 embryos, which have a complete
deletion of the Ptp52F gene (Fig. 1A), do not stain with anti-
DPTP52F mAbs. Embryos homozygous for point mutations in
Ptp52F (see below) also do not stain (Fig. 2D). These results
show that the mAbs selectively recognize DPTP52F. 
Perturbation of DPTP52F expression using RNAi
produces axon guidance phenotypes
Injected double-stranded RNA (dsRNA) is a potent and
specific inhibitor of gene expression in Drosophila; this
method of gene expression blockage is called RNA
interference (RNAi) (Kennerdell and Carthew, 1998;
Misquitta and Paterson, 1999); see also (Schmid et al., 2001).
We initially used RNAi to evaluate the functions of DPTP52F
during embryonic development. We examined motor axon
and CNS phenotypes in these embryos by staining them
with mAb 1D4 (Van Vactor et al., 1993), which recognizes
motor axons in the periphery and three paired longitudinal
bundles within the CNS. In abdominal segments A2-A7, ~32
motor axons exit the CNS within the ISN (intersegmental
nerve) and SN (segmental nerve) roots; these then split
into five pathways that innervate 30 muscle fibers (Keshishian
et al., 1996). The SNa and SNc pathways emerge from
the SN root, and the ISN, ISNb, and ISNd pathways arise
Fig. 3. CNS and motor axon phenotypes produced by RNAi. Dissected late stage 16 embryos stained with mAb 1D4. Column 1 (A,E,I), wild-
type. Column 2 (B,F,J), embryos injected with injection buffer. Column 3 (C,G,K), embryos injected with Dlar dsRNA. Column 4 (D,H,L),
embryos injected with Ptp52F dsRNA. Row 1 (A-D), the CNS (anterior up); note the 3 straight longitudinal bundles on each side of the midline
in A-C. Arrow in D indicates a break in the outer 1D4 bundle; arrowhead indicates abnormal fasciculation of the middle and outer bundles.
Row 2 (E-H), ISNb (anterior towards the left); note the 3 characteristic synaptic branches in E,F,H; muscles are numbered in E. Arrow in G,
bypass ISNb; arrowhead, ISN; asterisk, SNa. Row 3 (I-L), SNa; note the characteristic bifurcation in I-K, indicated by arrow in (I); muscle 12 is
also labeled. Asterisk in L, approximate position of missing bifurcation. 
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from the ISN root. ISNb and ISNd are also known as SNb
and SNd. 
To evaluate the efficacy of RNAi for perturbation of Rptp
gene expression, we first injected Dlar dsRNA into embryos
and allowed them to develop to stage 16-17. Injection of buffer
produced no phenotypes (Fig. 3B,F,J), whereas injection of
Dlar dsRNA phenocopied the characteristic Dlar mutant ISNb
phenotype, known as parallel bypass (Fig. 3G). In parallel
bypass hemisegments, ISNb leaves the ISN tract in an
apparently normal manner and continues to extend dorsally, but
fails to innervate its VLM targets (Krueger et al., 1996). In
Dlar RNAi embryos, 15% of hemisegments had parallel
bypass phenotypes. This penetrance is very similar to that
observed for zygotic Dlar null mutants (18%) (Desai et al.,
1997). SNa and CNS pathways are not affected in Dlar mutants
(Krueger et al., 1996), and these also appeared normal in Dlar
dsRNA-injected embryos (Fig. 3C,K).
We then injected two different Ptp52F dsRNAs derived from
overlapping sections of the Ptp52F cDNA. The two dsRNAs
produced identical phenotypes in which the 1D4-positive
bundles in the CNS are irregular and abnormally fasciculated.
The outer 1D4-positive bundle is often missing (Fig. 3D). 
The ISNb, ISNd and SNc motor nerves appeared identical to
wild type in Ptp52F RNAi embryos (Fig. 3H; data not shown).
The SNa nerve, however, displayed a clear and diagnostic
phenotype. SNa has a characteristic bifurcated morphology. The
bifurcation occurs at a choice point located between muscles 22
and 23. The posterior (or lateral) branch of the SNa innervates
muscles 5 and 8, and the anterior (or dorsal) branch innervates
muscles 21-24 (Fig. 3I). In embryos injected with Ptp52F
dsRNA, either the posterior or anterior branch was sometimes
missing (Fig. 3L). The penetrance of this bifurcation phenotype
was 18%. In summary, our RNAi experiments suggested that
DPTP52F is involved in guidance of longitudinal axons within
the CNS and in bifurcation of the SNa motor nerve.
Identification of Ptp52F mutants
We examined a collection of EMS-induced mutations that are
lethal over Df(2R)JP4, Df(2R)JP6 and Df(2R)JP8 (Fig. 1A) for
the Ptp52F CNS and SNa phenotypes that we had defined
using RNAi. There are 13 lethal complementation groups in
this interval. We collected embryos from lines representing
each of these complementation groups and stained them with
mAb 1D4. Mutations within one complementation group
produced phenotypes identical to those we had observed with
RNAi. This group consists of eight alleles. We sequenced the
Ptp52F gene from three of these alleles, and found the
following mis-sense mutations (Fig. 1C): Ptp52F18.3, Ser to
Pro in the fifth FN3 repeat (S941P), Ptp52F7.8.1, Pro to Ser in
the second FN3 repeat (P633S), and Ptp52F8.10.3, Tyr to Asn
in the PTP domain (Y1348N). 
Transheterozygous Ptp52F18.3/Df(2R)JP4 flies can survive
until the first instar larval phase. Ptp52F embryos appear
morphologically normal during all phases of development. The
peripheral nervous system (PNS) displays no defects, and the
pattern of body wall muscle fibers is also normal. There are
also no abnormalities in the patterns of expression of the Even-
skipped (Eve) and Engrailed (En) homeodomain proteins
during segmentation or later within the CNS, suggesting that
the fates of Eve- and En-expressing cells are not altered by
these mutations (data not shown). 
Embryos homozygous for any of the three Ptp52F alleles
express no detectable DPTP52F protein, as assayed by staining
with anti-DPTP52F mAbs (Fig. 2D). Embryos homozygous
for Ptp52F18.3 or transheterozygous for Ptp52F18.3 over
Df(2R)JP4 have approximately the same phenotypic
penetrances. Thus, Ptp52F18.3 may be a null allele. Ptp52F7.8.1
or Ptp52F8.10.3 produce the same phenotypes as Ptp52F18.3, but
with somewhat lower penetrances, suggesting that they may be
hypomorphic alleles (see Table 1, Table 2, Table 3). All of these
data indicate that the phenotypes described in more detail
below are due to the absence of the DPTP52F protein.
Ptp52F mutations perturb guidance of longitudinal
pioneer axons
At stages 16 and 17, mAb 1D4 stains three distinct axon
bundles in each longitudinal connective of the CNS, but
does not stain any commissural bundles. In Ptp52F18.3 and
Ptp52F18.3/Df(2R)JP4 embryos, a phenotype identical to that
observed in Ptp52F dsRNA-injected embryos is observed, in
which the longitudinal 1D4-positive bundles are wavy and
irregular and the outer bundle is discontinuous or missing
(Fig. 4B,C). The other two alleles produce weaker but similar
CNS phenotypes (data not shown). We do not observe clear
phenotypes in Ptp52F embryos stained with mAb BP102,
which stains all CNS axons (Seeger et al., 1993). This suggests
that only a subset of longitudinal axons is affected by the
mutations. 
To examine the establishment of longitudinal pathways, we
analyzed earlier (stage 12 and 13) embryos. During stage 12,
mAb 1D4 selectively stains the longitudinal pioneer neurons
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Table 1. SNa phenotypes in Rptp mutant embryos
Phenotype (%)*
Genotype n t M S A –
Ptp52F
Ptp52F18.3 145 37 19 5 14 0
Ptp52F18.3/Df(2R)JP4 137 41 20 7 10 4
Ptp52F18.3/Df(2R)JP8 149 32 9 3 19 0
Ptp52F8.10.3 150 28 9 0 18 0
Ptp52F8.10.3/Df(2R)JP4 100 36 12 4 20 0
Ptp52F8.10.3/Df(2R)JP8 109 22 7 0 16 0
Ptp52F7.8.1 138 27 14 0 27 0
Ptp52F7.8.1/Df(2R)JP4 101 36 12 2 22 0
Ptp52F7.8.1/Df(2R)JP8 129 22 7 0 16 0
Ptp10D Ptp52F
Ptp10D1Ptp52F18.3 175 61 25 33 2 3
Ptp10D1Ptp52F8.10.3 100 45 17 23 5 0
Dlar Ptp52F
Dlar5.5Ptp52F18.3 150 51 22 25 5 0
Ptp52F Ptp69D
Ptp52F18.3 Ptp69D1/Df(3L)8ex25 155 68 36 27 1 4
Ptp52F8.10.3 Ptp69D1/Df(3L)8ex25 101 51 29 17 2 3
Ptp52F Ptp99A
Ptp52F18.3 Ptp99A1 145 33 25 3 2 2
n, number of hemisegments (A2-A7) scored.
a, additional branches at random positions; M, either posterior or anterior
SNa branch is missing; S, SNa stalls near the bifurcation point; t, all affected
SNa branches; –, the whole SNa branch is missing.
The numbers listed are % of hemisegments displaying a particular
phenotype. Single Dlar, Ptp10D, Ptp69D and Ptp99A mutants are not listed,
as these seldom display SNa phenotypes (<5% abnormal hemisegments).
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MP1, dMP2 and pCC. pCC pioneers the pCC/vMP2 pathway,
which extends anteriorly over a 1D4-positive longitudinal glial
cell, LG5 (Fig. 5A) (Seeger et al., 1993). When we examined
Ptp52F mutants at slightly later stages (so as to be sure that
pCC should have contacted LG5), we observed that the pCC
growth cone was usually stalled and had not grown onto LG5
(Fig. 5B). 
The stalled pCC phenotype probably represents a delay in
growth cone extension rather than a complete block. By stage
13, the ascending pCC growth cone encounters the descending
axons of dMP2 and MP1. pCC/vMP2 and MP1/dMP2 then
establish a continuous longitudinal pathway (Fig. 5C). In
Ptp52F embryos examined at a later stage than the wild-type
embryo of Fig. 5C, this longitudinal pathway is still thin in
~50% of hemisegments, and the connection between pCC and
the pathway appears to be missing in some hemisegments
(Fig. 5D). This suggests that pCC growth cones might have
retracted or taken an alternate pathway after failing to contact
MP1 at the appropriate stage. By stage 15, however, the
medial 1D4-positive bundle, which contains the pCC axon
(Hidalgo and Brand, 1997), has a relatively normal appearance
(Fig. 4B,C). 
SNa pathways are altered in Ptp52F and double
mutants
Ptp52F mutants display a variety of SNa guidance defects. The
most common defect, as in Ptp52F RNAi embryos, is a failure
to bifurcate (Fig. 6C). In other hemisegments, the SNa has extra
branches (Fig. 6B), or stalls near the bifurcation point (Fig. 6D).
The penetrances of such SNa phenotypes in Ptp52F18.3
homozygotes or Ptp52F18.3/Df(2R)JP4 transheterozygotes are
37% and 41%, respectively. The two other Ptp52F alleles and
the transheterozygous combinations of the three Ptp52F alleles
with Df(2R)JP8 have a lower penetrance of SNa defects (22-
28%; Table 1).
Single mutants that lack any of the other four neural RPTPs
do not display SNa phenotypes. However, combinations of
Rptp mutations do affect the SNa (Sun et al., 2001). To evaluate
how removal of other RPTPs might affect Ptp52F SNa
phenotypes, we made double mutants lacking both DPTP52F
and each of the other RPTPs. We found that the absence of
DPTP10D, DPTP69D or DLAR increases the penetrance of the
Ptp52F18.3 defects, particularly those in which the SNa stalls
near the bifurcation point. No new phenotypes are observed in
double mutants, however. Removal of DPTP99A does not
affect the overall penetrance of SNa phenotypes, but does
decrease the frequency of ectopic branches (Table 1). 
Ptp10D Ptp52F and Ptp52F Ptp69D embryos display
synergistic ISNb phenotypes
The ISNb motor nerve innervates the VLMs and contains the
axons of the identified RP1, RP3, RP4 and RP5 motoneurons.
RP growth cones leave the common ISN pathway at the exit
junction, enter the VLM field, and then navigate among the
muscle fibers. Synapses begin to form at stereotyped positions
by late stage 16 (Fig. 7A). Ptp52F mutations produce any
detectable ISNb phenotypes only at low frequencies (<13%;
Table 2). 
Table 2. ISNb phenotypes in Rptp mutant embryos
Phenotype (%)*
Genotype n t B S
Ptp52F
Ptp52F18.3 145 7 1 6
Ptp52F18.3/Df(2R)JP4 136 13 2 11
Ptp52F18.3/Df(2R)JP8 150 5 1 4
Ptp52F8.10.3 150 1 0 1
Ptp52F8.10.3/Df(2R)JP4 100 4 0 4
Ptp52F8.10.3/Df(2R)JP8 110 1 0 1
Ptp52F7.8.1 138 3 0 3
Ptp52F7.8.1/Df(2R)JP4 100 5 0 5
Ptp52F7.8.1/Df(2R)JP8 130 2 0 2
Ptp10D Ptp52F
Ptp10D1Ptp52F18.3 175 40 1 39
Ptp10D1Ptp52F8.10.3 100 32 2 30
Dlar and Dlar Ptp52F
Dlar5.5/Dlar13.2 260 35 31 4
Dlar5.5 Ptp52F18.3 146 40 23 17
Ptp69D and Ptp52F Ptp69D
Ptp69D1/Df(3L)8ex25 141 3 2 1
Ptp52F18.3 Ptp69D1/Df(3L)8ex25 155 29 3 26
Ptp52F8.10.3 Ptp69D1/Df(3L)8ex25 101 22 2 20
Ptp52F Ptp99A
Ptp52F18.3 Ptp99A1 145 15 1 14
n, number of hemisegments (A2-A7) scored.
B, bypass ISNbs; S, ISNbs that stall within the VLM field; t, all affected
ISNb branches.
The numbers listed are % of hemisegments displaying a particular
phenotype. Single Ptp10D and Ptp99A mutants are not listed, as these have
no ISNb phenotypes (<2% abnormal hemisegments).
Table 3. ISN phenotypes in Rptp mutant embryos
Phenotype (%)*
Genotype n t T SB FB 1–
Ptp52F
Ptp52F18.3 166 16 1 12 2 0
Ptp52F18.3/Df(2R)JP4 157 20 0 17 3 0
Ptp52F18.3/Df(2R)JP8 175 11 7 2 2 0
Ptp52F8.10.3 177 5 0 5 0 0
Ptp52F8.10.3/Df(2R)JP4 120 14 10 4 0 0
Ptp52F8.10.3/Df(2R)JP8 127 4 4 0 0 0
Ptp52F7.8.1 160 7 6 1 0 0
Ptp52F7.8.1/Df(2R)JP4 117 15 6 9 0 0
Ptp52F7.8.1/Df(2R)JP8 151 5 5 1 0 0
Ptp10D Ptp52F
Ptp10D1Ptp52F18.3 207 67 40 23 4 0
Ptp10D1Ptp52F8.10.3 119 49 35 13 1 0
Dlar and Ptp52F
Dlar5.5/Dlar13.2 256 41 22 19 0 0
Dlar5.5Ptp52F18.3 166 64 51 10 2 2
Ptp69D and Ptp52F Ptp69D
Ptp69D1/Df(3L)8ex25 131 1 1 0 0 0
Ptp52F18.3 Ptp69D1/Df(3L)8ex25 182 58 1 57 1 0
Ptp52F8.10.3 Ptp69D1/Df(3L)8ex25 117 47 7 40 0 0
Ptp52F Ptp99A
Ptp52F18.3 Ptp99A1 173 27 4 18 3 1
n, number of hemisegments (A2-A7) scored.
FB, ISNs that terminate at the first branchpoint; SB, ISNs that terminate at
the second branchpoint; t, all affected ISN branches; T, ISNs that appear to
reach the terminal arbor position, but are thin or bifurcated; 1–, ISNs that
terminate proximal to the first branchpoint.
The numbers listed are % of hemisegments displaying a particular
phenotype. Single Ptp10D and Ptp99A mutants are not listed, as these have
no ISNb phenotypes (<2% abnormal hemisegments).
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Ptp10D mutations produce no ISNb phenotypes (Sun et al.,
2001). Removal of both DPTP10D and DPTP52F, however,
generates a strong phenotype in which the ISNb stalls within
the VLMs, often at the proximal edge of muscle 13 (Fig. 7B).
This stall phenotype is observed in Ptp52F single mutants, but
its frequency can be dramatically increased in double mutants
(1%fi 30% for addition of a Ptp10D mutation to the
hypomorphic mutation Ptp52F8.10.3; Table 2). Removal of
DPTP69D also greatly enhances the Ptp52F stall phenotype
(1%fi 20% for Ptp52F8.10.3; Table 2). 
Dlar Ptp52F double mutants have parallel bypass
phenotypes identical to those of Dlar single mutants (Krueger
et al., 1996). Ptp99A mutations cause no ISNb phenotypes on
their own or in combination with Ptp52F (Table 2).
DPTP52F regulates ISN outgrowth
The ISN passes its first (FB) and second (SB) lateral
branchpoints before reaching the position of its terminal arbor
at the proximal edge of muscle 1 (Fig. 7C). In Ptp52F mutants,
most ISNs are normal (Fig. 7C), but 5-17% terminate at SB
(Table 3). Dlar mutations produce SB phenotypes with a
similar penetrance (19% for null alleles) (Desai et al., 1997).
When Dlar and Ptp52F mutations are combined, the frequency
of the SB termination phenotype is similar to those of the single
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Fig. 4. CNS phenotypes in Ptp52F
and double mutants. Dissected late
stage 16 embryos stained with mAb
1D4. (A) wild-type. (B) Ptp52F18.3.
(C) Ptp52F18.3/Df(2R)JP4. The
bundles are wavy and disorganized
in B,C, and the outer bundle is
sometimes missing (bracket).
(B,C,E) Abnormal fasciculation of
the middle and outer bundles
(arrowheads). (D) Dlar5.5Ptp52F18.3.
Bundle morphology in this double
mutant reverts to wild type (compare
with A-C). (E) Ptp10D1,Ptp52F18.3.
(F) Ptp52F18.3,
Ptp69D1/Df(3L)8ex25. 1D4-positive
bundles in these two double mutants
are more disorganized than in B,C,
and the middle bundle is strongly
affected (asterisks). Arrow, complete
connective break. 
Fig. 5. The pCC growth cone stalls in Ptp52F mutants.
Dissected embryos stained with mAb 1D4. (A) wild-type,
late stage 12. aCC growth cones (a) have just begun to turn
outwards. The pCC growth cone has already grown onto
the 1D4-positive LG5 cell (bracket) in the hemisegments
on the right (indicated by parallel lines flanking the pCC
axon connection to LG5). (B) Ptp52F18.3, early stage 13.
The aCC growth cone (a) has already turned posteriorly
and then begun to extend away from the CNS, but the pCC
growth cones (p) have still not reached LG5. (C) Wild-
type, early stage 13. The aCC growth cone (a) is at the
same position as the one indicated in B. A continuous
longitudinal pathway has formed. pCC axons are indicated
by flanking parallel lines. (D) Ptp52F18.3, late stage 13.
The aCC axons (a) have already extended beyond the
edges of the panel, but there are still gaps in the
longitudinal pathways on the left side (arrows) just
anterior to the pCC cell bodies. 
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mutants. Ptp99A mutations have no effects on ISN on their
own, and also cause no enhancement of the Ptp52F phenotype
(Table 3).
Ptp10D and Ptp69D single and double mutants have no ISN
phenotypes (Fig. 7D) (Sun et al., 2001). However, removal of
either of these RPTPs from a Ptp52F mutant background
enhances the penetrances of the Ptp52F ISN phenotypes.
Ptp10D Ptp52F double mutants have a reduced terminal arbor
(T) phenotype (35%; Fig. 7E) that is less frequently observed
in Ptp52F single mutants (<10%). Removal of DPTP69D does
not affect the T phenotype, but produces an increase in the SB
phenotype (5% fi 40% for Ptp52F8.10.3; Table 3; Fig. 7F). In
summary, our results indicate that DPTP52F, DPTP10D and
DPTP69D have partially redundant functions in regulation of
ISN outgrowth. It is interesting that Ptp52F mutations do not
produce synergistic phenotypes when combined with Dlar
mutations, which are the only other Rptp mutations that
generate strong ISN phenotypes on their own. Perhaps there
are two separate ‘functions’ needed for normal ISN outgrowth,
one of which involves DLAR and the other DPTP52F. 
Removal of DLAR suppresses the Ptp52F CNS
phenotype 
DPTP52F is the only RPTP whose removal produces clear
phenotypes in the 1D4-positive longitudinal bundles of the
CNS. The 1D4 pathways are usually indistinguishable from
wild type in single mutants lacking each of the other four
RPTPs. Removal of DPTP10D or DPTP69D from a Ptp52F
background strengthens the Ptp52F CNS phenotype. The
longitudinal 1D4-positive bundles become more irregular, and
frequent breaks and discontinuities in the middle bundle are
observed (Fig. 4E,F). We do not, however, observe a new
synergistic phenotype like that produced by removal of
DPTP10D and DPTP69D together (Sun et al., 2000). Removal
of DPTP99A does not affect the Ptp52F CNS phenotype (data
not shown). 
In contrast to these results, we find that when a Dlar
mutation is introduced into a Ptp52F mutant background, the
morphology of the 1D4-positive bundles reverts to wild type
(Fig. 4D). In a few segments of Dlar Ptp52F double mutants,
breaks in the outer 1D4-positive bundle are still seen, but
defasciculation and irregularities in the inner two bundles
are not observed. The suppression is specific to the CNS
Fig. 6. SNa phenotypes in Ptp52F mutants. Dissected late stage 16
embryos stained with mAb 1D4. (A) Wild type. The SNa bifurcation
(arrow) and muscle 12 are indicated. (B-D) Ptp52F18.3. There is an
extra branch in B (arrow). The anterior branch is missing in C. Most
SNa axons appear to stall near the bifurcation point in D (arrow). 
Fig. 7. ISNb and ISN phenotypes in Ptp52F and double mutants.
Dissected late stage 16 embryos stained with mAb 1D4.
(A) Ptp52F18.3. The ISNb has a normal appearance. Muscles are
labeled. (B) Ptp10D1, Ptp52F8.10.3.. The left ISNb has stalled at the
proximal edge of muscle 13 (arrow) without making a synaptic
branch. The right ISNb is also truncated. The distal portion of the
ISN is shown in C-F. Terminal arbors are indicated by arrowheads in
C,E; the large tracheal branch just distal to the second branchpoint is
indicated by asterisks in C-F. (C) Ptp52F8.10.3.
(D) Ptp69D1/Df(3L)8ex25. The ISN has a normal appearance in
these single mutants. (E) Ptp10D1, Ptp52F8.10.3.. Terminal arbors are
reduced in this double mutant. (F) Ptp52F8.10.3,
Ptp69D1/Df(3L)8ex25. ISNs stall at the second branchpoint position
(arrow), proximal to the tracheal branch. 
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phenotypes detected at late stage 16, because the introduction
of Dlar mutations into a Ptp52F mutant background does not
correct the failure of the pCC growth cone to extend at the
appropriate time. 
DISCUSSION
We describe a new Drosophila RPTP, DPTP52F. This is the
sixth RPTP to be identified in the fruit fly, and our analysis
indicates that there are unlikely to be any other RPTPs encoded
in the genome. DPTP52F is selectively expressed in CNS
neurons in late embryos. We isolated mutations in the Ptp52F
gene, and showed that Ptp52F mutant embryos have specific
motor axon and CNS axon guidance defects. Previous studies
by our group and by others have shown that mutations affecting
four other RPTPs also produce axon guidance and
synaptogenesis phenotypes. In summary, this work suggests
that the major functions of at least five of the six Drosophila
RPTPs are to facilitate the correct wiring of the nervous
system. 
RPTPs in flies, worms and humans
The existence of complete genome sequences for humans,
Drosophila and the nematode C. elegans allows the
determination of how many members of each gene family are
required for development and function of these metazoans. We
find that Drosophila has 14 genes encoding tyrosine-specific
phosphatases: six Rptp genes and eight genes encoding
potentially active PTPs without transmembrane domains
(cytoplasmic PTPs). The two new cytoplasmic PTPs we
identified are now called PEZ/CG9493 (DPTP26C) and
CG7180 (DPTP36E). The completed genome sequence
allowed identification of three additional PTP genes at 8F
(CG3101), 61C (CG1228) and 86F (CG14714); none of these
is likely to encode RPTPs (Table 4). 
These conclusions differ from those in a review of kinase
and phosphatase sequences in the fly genome (Morrison et al.,
2000), in which CG7180 (DPTP36E) and CG4355 were
classified as RPTPs. We isolated and sequenced DPTP36E
cDNA clones, and these do not encode an extracellular region.
CG4355 is closely related to phogrin, a transmembrane rat
phosphatase-related protein expressed on secretory granules,
but the Drosophila protein lacks the essential active-site
cysteine and has no homology to the extracellular-like
(lumenal) domain of phogrin.
C. elegans has many more RPTPs (15) and cytoplasmic
PTPs (>57) than does the fly (Table 4) (Hutter et al., 2000;
Plowman et al., 1999). To determine how many PTPs are
encoded in the human genome, we examined the Celera human
genome sequence database (Venter et al., 2001). Surprisingly,
our analysis showed that all of the genes that are likely to
encode functional human PTPs have already been identified by
PCR techniques or by ESTs. The human genome appears to
encode 17 active RPTPs and 16 cytoplasmic PTPs. We also
found nine PTP pseudogenes that had not been previously
identified. 
Two human PTP-like genes (IA-2 and phogrin) encode
orthologs of CG4355 in Drosophila and ida-1 in C. elegans
(Zahn et al., 2001). All of these proteins contain sequence
changes at crucial positions, indicating that they do not
function as active phosphatases (Cai et al., 2001; Magistrelli et
al., 1996). 
Three of the six Drosophila RPTPs have human and C.
elegans counterparts, as follows: 
(1) The DPTP10D/DPTP4E subfamily (Type III) is
characterized by a large number of FN3 repeats ( ‡ 8) and a
single PTP domain. It has a single member in C. elegans
(F44G4.8), two members in Drosophila (DPTP10D and
DPTP4E), and five members in humans (HPTP b, HPTPh ,
GLEPP-1, Sap-1 and PTP-RQ). PTP-RQ is only defined in
humans by a 134 amino acid fragment, but our analysis
indicates that the complete protein is >2000 amino acids and
is the ortholog of rat rPTP-GMC1. 
(2) The LAR subfamily (Type IIa) has three Ig domains and
eight or nine FN3 repeats, and two PTP domains. It has a single
member in C. elegans (C09D8.1) and Drosophila (DLAR) and
three members in humans (LAR, PTP d , and PTP s ). 
Two other fly RPTPs have counterparts in C. elegans but no
obvious human orthologs: 
(1) DPTP69D has two Ig domains and three FN3 repeats,
and is probably orthologous to C. elegans CLR-1. 
(2) DPTP99A corresponds to worm K04D7.4. It has three
FN3 repeats and two PTP domains, but the second domain
lacks the essential cysteine residue. DPTP69D and DPTP99A
have been classified as Type IIa (LAR-like) and Type III
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Table 4. PTPs in the Drosophila genome
(A) PTP superfamily genes in fly, worm and human
Fly Worm
Group Fly fragments Worm* fragments* Human
cPTP 8 2 57 4 17‡
RPTP 6 0 26? (15) 14? 16
DSP 13 4 65 0 n.d.
LMW 2 0 n.d. n.d. n.d.
(B) Complete tyrosine-specific phosphatases
GG Name Type Domains Worm ortholog
6899 DPTP4E RPTP FN3 F44G4.8 (1e-100)
1817 DPTP10D RPTP FN3 F44G4.8 (4.4e-104)
10443 DLAR RPTP FN3, Ig C09D8.1 (0.0)
18243 DPTP52F RPTP FN3 –
10975 DPTP69D RPTP FN3, Ig CLR-1 (1.1e-101)
or C09D8.1 (2e-103)
2005 DPTP99A RPTP FN3 K04D7.4 (6.3e-82)
9181 DPTP61F cPTP –
3954 CSW cPTP SH2 PTP-2 (1.4e-70)
1228 PTPMEG cPTP PDZ, ezrin PTP-1 (6.1e-156)
9493 PEZ cPTP Ezrin C48D5.2A (4e-36)
9856 PTP-ER cPTP –
3101 cPTP –
14714 cPTP –
7180 cPTP T13H5.1 (1.3e-108)
*Data from Plowman et al. (Plowman et al., 1999). Hutter et al. (Hutter et
al., 2000), however, find only 15 worm RPTPs, and we concur with this
number.
‡There are also two inactive PTP-like proteins, and at least nine
pseudogenes.
cPTP, cytoplasmic PTP; DSP, dual-specificity phosphatase; FN3,
fibronectin type III repeat; Ig, immunoglobulin-like domain; LMW, low
molecular weight phosphatase; n.d., not determined; RPTP, receptor-linked
PTP; –, no clear ortholog.
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(DPTP10D-like), respectively, but this may be incorrect, as
their domain organizations differ from the other members of
these subfamilies. 
DPTP52F does not have clear nematode or human orthologs.
It is equally related to a number of different PTPs. DPTP52F
might be classified as a member of the DPTP10D/DPTP4E
(Type III) subfamily, however, as it has an XC domain with
FN3 repeats and only one cytoplasmic PTP domain. 
The 11 C. elegans RPTPs that are not orthologous to
Drosophila or human RPTPs all have a nematode-specific
extracellular domain denoted as FE (Hutter et al., 2000). This
domain has no close relatives in Drosophila or other sequenced
species.
The human genome encodes nine RPTPs in four subfamilies
not found in worms or flies: (1) MAM domain RPTPs (Type
IIb), some of which can function as homophilic adhesion
molecules (PTPm , PTPk , PTP r and PTP o ); (2) Carbonic
anhydrase domain-containing (Type V) RPTPs (PTPz and
PTP g ); (3) Type IV RPTPs, which have short glycosylated
extracellular domains (PTPa and PTP e ); and (4) CD45 (Type
I). (Most human RPTPs have several names, and one name was
arbitrarily selected here; see Materials and Methods for listings
of all names).
Regulation of axon guidance by DPTP52F
To evaluate the functions of DPTP52F during development, we
first used RNAi to inhibit its expression. Ptp52F RNAi
embryos have distinctive motor axon and CNS phenotypes
(Fig. 3). We used these phenotypes as a tool for analysis of a
set of lethal mutations within the interval containing the
Ptp52F gene. Mutations in one complementation group
produced phenotypes identical to those observed with RNAi.
We sequenced the Ptp52F gene from three mutant lines and
found nonconservative missense substitution mutations (Fig.
1). Embryos from all three mutant lines fail to stain with anti-
DPTP52F mAb, suggesting that the mutant proteins do not fold
correctly or are unstable (Fig. 2).
We characterized motor axon phenotypes produced by these
mutations. In Ptp52F mutants, the SNa motor nerve fails to
bifurcate in a normal manner in about 40% of hemisegments
(Table 1). SNa normally splits into anterior and posterior
branches at a choice point just distal to muscle 12. Mutant SNa
nerves lack either the anterior or posterior branches with
approximately equal frequency. SNa nerves can also have
ectopic branches or stall near the normal bifurcation point
(Fig. 6). 
To further examine the roles of DPTP52F in regulating
motor axon guidance, we made double mutants lacking
DPTP52F together with each of the other four neural RPTPs.
Our earlier work has defined three modes of genetic interaction
among Rptp genes: partial redundancy (a guidance decision
can be facilitated by any one of a set of RPTPs), collaboration
(expression of two specific RPTPs is required to allow a
decision to take place) and competition (loss-of-function
mutations in one Rptp gene suppress a phenotype produced by
mutations in the other gene). Some of these genetic interactions
could be explained by formation of RPTP heteromultimers
(Sun et al., 2001).
Ptp52F exhibits both partial redundancy and competition in
its interactions with the other Rptp genes. It has strong
interactions with Ptp10D, Dlar and Ptp69D, but not with
Ptp99A. Interactions with Ptp10D and Ptp69D are synergistic:
both the CNS and motor axon phenotypes are worsened in
double mutants. In some cases, there is a dramatic difference
between double mutants and either single mutant. For example,
the ISNb stall phenotype is almost never observed in either
Ptp52F (hypomorph) or Ptp10D mutants (1% of
hemisegments), while 30% of hemisegments have this
phenotype in double mutants (Table 2). These kinds of
interactions suggest that some process needed for ISNb
extension through the VLM field can be mediated by either
DPTP10D or DPTP52F, and this process only fails when both
are missing. 
Ptp52F embryos have longitudinal tract phenotypes in
which the 1D4-positive bundles are irregular and the outer
bundle is often missing. These phenotypes are absent in Dlar
Ptp52F double mutants, suggesting that DLAR and DPTP52F
interact in a competitive manner to regulate longitudinal tract
axon guidance/outgrowth decisions (Fig. 4). Dlar does not
suppress the Ptp52F SNa or ISN phenotypes, however, so these
two RPTPs do not always interact competitively. 
DLAR also participates in another competitive interaction:
the Dlar ISNb parallel bypass phenotype is absent in Dlar
Ptp99A double mutants (Desai et al., 1997). Here, however, it
is a Dlar phenotype that is suppressed by removal of another
RPTP, rather than the reverse. Ptp52F mutations do not affect
Dlar parallel bypass phenotypes. Determination of the
mechanisms that underlie these genetic interactions will
require biochemical analysis of DPTP5F and of the signaling
pathways in which it participates. 
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